Wexford Capital’s Microbot Medical MBOT Stock Holding History

Wexford Capital’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,276	Closed	-$49.6K	–	466
2025 Q3	$49.6K	Buy	+16,276	New	+$50.8K	0.01%	304

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wexford Capital's MBOT Position: Q4 2025 in Review

Wexford Capital sold out of Microbot Medical (MBOT) in Q4 2025, closing a stake of 16,276 shares — an estimated $49.6K sold.

Wexford Capital first reported a position in MBOT in Q3 2025 and held it in 1 quarter. The position peaked at $49.6K in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

Wexford Capital reported no remaining Microbot Medical position as of Q4 2025 after selling out during the quarter.
Wexford Capital sold 16,276 Microbot Medical shares in Q4 2025, an estimated $49.6K.
Wexford Capital first reported a position in Microbot Medical in Q3 2025 and held it in 1 quarter.
Wexford Capital's Microbot Medical position peaked at $49.6K in Q3 2025.
70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on Wexford Capital's 13F filing for Q4 2025, filed 13 Feb 2026.